Goldline Pharmaceuticals IPO allotment: The basis of allotment of Goldline Pharmaceuticals is expected to be finalised on Friday, May 15, 2026. The bid finalisation details will be available on the websites of the BSE and Bigshare Services.
The initial public offering was subscribed 781.85 times, with bids for 1,53,86,88,000 shares as against 19,68,000 shares on offer, according to the BSE website.
The part reserved for non-institutional investors (NIIs) was subscribed 1,227.90 times, while the individual investors' quota was booked 881.15 times. The portion for qualified institutional buyers (QIBs) saw 180.22 times the subscription.
The ₹11.61 crore initial share sale was purely a fresh issuance of 27 lakh shares, with no offer for sale (OFS) component.
The funds generated will be utilised for repayment of certain outstanding borrowings availed by the company and general corporate purposes.
With a price band of ₹41 to ₹43 per share, a lot consisted of 3,000 shares. The minimum investment for an individual investor was two lots or 6,000 shares.
Goldline Pharmaceutical markets pharmaceutical products under its proprietary brand 'Goldline'. The firm does not produce any products itself but operates through a third-party manufacturing model through contractual arrangements with makers who manufacture products based on Goldline's market research, specifications and demand analysis.
Goldline Pharmaceuticals IPO allotment date and time
Goldline Pharmaceuticals IPO allotment status is likely to be finalised on Friday, May 15, by late evening.
Reliance Jio Platforms IPO:Akash Ambani appointed as MD for five years ahead of public issue
How to check Goldline Pharmaceuticals IPO allotment status online on BSE
- Go to BSE's IPO allotment status page: https://bseindia.com/investors/appli_check.aspx
- Issue type should be kept as 'Equity'
- Select 'Goldline Pharmaceuticals Ltd' from issue names
- Mention PAN details or IPO application number
- Press the 'Search' button to see the allotment details
Steps to check Goldline Pharmaceuticals IPO allotment status online on Bigshare Services
- Visit this link: www.bigshareonline.com/ipo_Allotment.html
- From three servers available, choose one
- Click on 'Goldline Pharmaceuticals Ltd' from the list of IPO names
- Add either application number, PAN or beneficiary ID
- Complete captcha verification
- Press the 'Search' button
Goldline Pharmaceuticals IPO listing date and time
Shares of Goldline Pharmaceuticals will be listed on the BSE SME platform on May 19 at 10 am.
Goldline Pharmaceuticals IPO GMP
According to investorgain.com and media reports, Goldline Pharmaceuticals' unlisted shares are trading at ₹58, reflecting a grey market premium (GMP) of 34.88% compared to the upper price band of ₹43.
Disclaimer: Grey Market Premium (GMP) is not regulated or recommended by the stock exchanges or SEBI. Upstox does not endorse or facilitate trading in the grey market. Investors are advised to conduct their own research or consult an expert before making any investment decisions.